<p>Despite aggressive surgical resection, cytotoxic chemotherapy, and external beam radiotherapy, most cases of glioblastoma (GBM) remain recalcitrant. These outcomes necessitate novel developmental therapeutics that spare normal tissue. Immunotherapy is a promising novel adjuvant treatment that can harness the cytotoxic capacity of the immune system against tumor-associated antigens with exquisite specificity. To circumvent the challenges associated with the advancement of adoptive cellular immunotherapy, we developed a novel treatment platform, which leverages the use of commercially available and clinically translatable nanoparticles (NPs) that can be combined with tumor derived RNA to peripherally activate T cells against GBM antigens. Although cancer vaccines have suffered from weak immunogenicity, we have advanced a NP vaccine formulation that can reshape a host’s immune profile through combinatorial delivery of RNAs encoding for tumor antigens and RNAs encoding for immunomodulatory molecules to mediate long-lived T cell persistence. </p><p>We sought to assess if vaccination with amplified tumor derived RNA encapsulated in lipophilic NPs could be assembled to transfect antigen presenting cells (APCs) in vivo and induce therapeutic anti-tumor immunity in pre-clinical murine tumor models. We hypothesized that RNA encapsulated nanoliposomes would localize to reticuloendothelial organs such as the spleen and liver, transfect APCs therein and induce peripheral antigen specific T cell immunity against GBM. Since activated T cells can cross the blood brain barrier and exert their effector functions against GBM antigens, peripheral transfection of APCs by RNA-NPs represents an attractive vaccination approach for priming endogenous immunity against refractory brain tumors.</p><p>We screened several translatable NP formulations for their ability to transfect dendritic cells (DCs) in vitro with GFP mRNA. We demonstrated that the NP DOTAP was the most promising translatable formulation compared to alternative cationic liposomal preparations and linear polyethylenimine NPs with and without DC targeting mannose receptors. RNA-NP vaccines formulated in DOTAP were shown to induce in vivo gene expression and preserve RNA stability over time. We determined that intravenous (IV) injection of RNA-NPs was requisite for inducing functional antigen specific immunity, which was superior to standard peptide vaccines formulated in complete Freund’s adjuvant (CFA). IV administered RNA-NPs localized to splenic and hepatic white blood cells (WBCs); these cells expanded antigen specific T cells when transferred to naïve immunocompetent mice. RNA-NPs induced increased percentages of B7 co-stimulatory molecules, but also elicited compensatory PD-L1 expression. We enhanced the immunogenicity and anti-tumor efficacy of RNA-NP vaccines by combining RNA-NPs with immune checkpoint blockade against PD-L1. We also enhanced the immunogenicity and efficacy of this platform by simply combining mRNAs encoding for immunomodulatory cytokines (i.e. GM-CSF). Finally, we demonstrated that RNA-NP vaccines mediate anti-tumor efficacy against intracranial and subcutaneous melanomas and engender therapeutic anti-tumor efficacy in a cellular immunotherapy model against a radiation/temozolomide resistant invasive murine high-grade glioma.</p><p>GBM remains invariably associated with poor patient outcomes thus necessitating development of more targeted therapeutics. Clinically translatable RNA-NPs form stable complexes making them amenable to overnight shipping. They induce potent immune responses when administered systemically and mediate robust anti-tumor efficacy that can be enhanced through co-delivery of immunomodulatory RNAs. </p><p>This technology can simultaneously bypass the complexity of cellular therapeutics while cutting down the time to generation of personalized vaccines. Since RNA-NP vaccines can be made within days from a tumor biopsy, providing near immediate immune induction against GBM, these formulations can provide a more feasible and effective therapy with a wide range of applicability for all malignancies that can be targeted using RNA obtained from surgical resection of solid tumors.</p> / Dissertation

Orientador: Maria Helena Andrade Santana / Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Engenharia Quimica / Made available in DSpace on 2018-08-08T14:24:33Z (GMT). No. of bitstreams: 1 Torre_LucimaraGazioladela_D.pdf: 28769884 bytes, checksum: 485f026c87d2f5b4fb99e642474200d0 (MD5) Previous issue date: 2006 / Resumo: Este trabalho visa o desenvolvimento tecnológico de uma vacina gênica, destinada ao combate à tuberculose, na qual o DNA encontra-se veiculado em lipossomas. Foram enfocados três aspectos principais: 1.A preparação e caracterização de estruturas lipídicas funcionais veiculando o DNA, projetadas para atenderem aos requisitos de imunização contra a tuberculose; 2. Complexação do DNA com peptídio sintético promotor de transporte nuclear e veiculação na estrutura lipossomal que se mostrou mais promissora nos ensaios in vitro e in vivo realizados no CPT-RP. 3. Análise do escalonamento da produção da estrutura lipossomal mais promissora para subsequente veiculação do DNA. Duas estruturas lipossomais foram compostas por lipídios com as seguintes funcionalidades: estrutural, de incorporação do DNA e atração eletrostática com a superfície das células, de intensificação da liberação do DNA no citoplasma celular. Foram preparadas pelo método da desidratação-rehidratação, gerando DRVs (¿dehydrated-hydrated vesicles¿). O DNA foi associado à essas estruturas, localizando-se no interior, [DRV(DNA)] ou prefencialmente na sua superfície [DRV-DNA]. A terceira estrutura, um agregado lipídico não lipossomal designado por lipoplexo, foi preparado na ausência do lipídio estrutural, contendo o DNA associado em toda a sua superfície. As estruturas foram caracterizadas através do seu diâmetro hidrodinâmico e distribuição de tamanhos, razão de cargas para completa incorporação do DNA, carga superficial, transição de fases, acessibilidade de sonda de fluorescência ao DNA e morfologia. O peptídio sintético com seqüência não convencional foi associado à estrutura DRV-DNA. O escalonamento da produção de lipossomas foi analisado através de dados experimentais e simulação matemática da cinética de produção de lipossomas em sistema multitubular. Dos resultados conclui-se que a estrutura DRV-DNA é promissora para a produção de vacina contra a tuberculose tanto pela sua efetividade biológica quanto do ponto de vista tecnológico / Abstract: This work contributes to the technological development of a gene vaccine against tuberculosis, where DNA is transported within liposomes. The three main aspects focused on were: 1. Functional lipid structures for DNA delivery were prepared and characterized in the attempt to obtain immunization standards against tuberculosis; 2. The best lipid structure was chosen from in vitro and in vivo assays performed in the ¿Centro de Pesquisas em Tuberculose de Ribeirão Preto¿ ¿ CPT-RP. A synthetic peptide that promotes nuclear transport was complexed to DNA and included into the best lipid structure. 3. Scale up analysis for the production of the best lipid structure that was used for DNA delivery. Two types of liposomes were composed by lipids with the following properties: (i) structure, (ii) DNA incorporation and electrostatic attraction with cell surface, and (iii) helper, that facilitates the DNA release to the citosol. These structures were prepared by the dehydrated-hydrated method, generating DRVs (dehydrated-hydrated vesicles). The DNA was associated in the inner compartment, [DRV(DNA)], or mostly at the surface [DRV-DNA] of these structures. The third structure, a lipid aggregate that does not form liposomes and was named lipoplex, was prepared in the absence of the structural lipid, used in previous preparations, which contained DNA associated with all of the aggregate¿s surface. The physico-chemical characterization of the structures were based on the hydrodynamic diameter and size distribution of the lipid particles, charge ratio for DNA incorporation into the lipid structure, surface charge, phase transition temperatures, the fluorescent probe accessibility to DNA and morphology of the particles. A synthetic peptide, with non-conventional sequence was associated to the DRV-DNA structure. The scale up for the liposome production was analyzed through the acquisition of experimental data and mathematical simulation of the liposomes production in a multitubular system. The results demonstrate that the incorporation of DNA into a lipid structure is very promising as a tuberculosis vaccine, especially in regards to the complexation of DNA with empty DRVs. The technological aspects of scaling up also confirm the viability of preformed liposomes production / Doutorado / Desenvolvimento de Processos Biotecnologicos / Doutor em Engenharia Química

Ce travail consiste à utiliser deux systèmes microfluidiques de gouttes pour incorporer d'une part des acides nucléiques dans des liposomes cationiques et d'autre part étudier la dynamique de transfection dans des cellules mammifères. La première micropuce permet d'insérer de l'ADN dans des liposomes cationiques afin d'obtenir de manière reproductible des lipoplexes appropriés à la transfection de cellules dendritiques (DC). Plusieurs paramètres expérimentaux sont tout d'abord étudiés, tels que les débits d'entrée, l’entretien des propriétés des liposomes après leur traitement dans des micro-gouttes, les caractéristiques des lipoplexes (taille, polydispersité et charge) en fonction du rapport molaire de charge (R+/-) et de la géométrie de la puce. Ensuite, les lipoplexes produits dans des conditions optimisées: une micropuce avec un grand canal en serpentin et une région de division des gouttes qui diminuent la polydispersité des lipoplexes, fonctionnant à un rapport de débit eau/huile 0,25 et R+/- 1,5; 3; 5; 7 et 10; sont utilisés pour transfecter des DCs in vitro. Tous les lipoplexes transfectent les DCs, tout en offrant une activation des DCs. La seconde étape consiste à utiliser une micropuce à l'échelle de la cellule unique afin de contrôler les conditions de transfection et d'optimiser le rendement de production de protéines recombinantes. Ainsi, des cellules ovariennes de hamster Chinois (CHO-S) sont transfectées dans la micropuce avec différents types de lipoplexes (R+/- 1,5; 3; 5) dont la dynamique de transfection est suivie par la production de protéines vertes fluorescentes (GFP) et par la viabilité cellulaire. Cette micropuce a permis d'évaluer l’hétérogénéité des cellules transfectées, révélant la présence d'une sous-population produisant des niveaux particulièrement élevés de GFP. Ces hautes productrices (HP) ont une taille cellulaire plus importante que celle de la population moyenne. La charge des lipoplexes montre un rôle important pour transfecter CHO-S, puisque l’unique lipoplex chargé positif R+/- 5 produit plus de HPs. La quantité d’ADN délivrée influe sur la production de protéine, puisque R+/- 1,5 avec plus d’ADN augmente la productivité spécifique de GFP des HPs. Cette thèse est réalisée dans le cadre d'un programme de co-tutelle entre l'Université de Campinas, au Brésil, et l'École Polytechnique, en France. Ce travail a principalement contribué aux domaines de microfluidique et de délivrance de gènes. / This work aims to use one droplet-based microfluidic systems to incorporate nucleic acids into cationic liposomes and another one to study the mammalian cell transfection process. For this, the first step uses a droplet-based microfluidic system to complex cationic liposomes with pDNA in order to obtain reproducible and suitable lipoplexes to dendritic cells (DCs) transfection. For this purpose, some experimental parameters are investigated, such as inlet flow rates, the maintenance of liposomes’ properties after microfluidic processing, lipoplex characteristics (size, polydispersity and zeta potential) as function of molar charge ratio (R+/-) and microchip design. Then, lipoplexes produced in selected conditions: a microchip with large serpentine channel and split region, which decreases lipoplex polydispersity, operating at ratio aqueous/oil flow rate 0.25 and R+/- 1.5, 3, 5, 7 and 10; are used to transfect DCs in vitro. All lipoplexes transfect DCs while providing cells activation. The second step uses a single-cell microfluidic platform to investigate and control over the transfection conditions, in view of optimizing the recombinant protein production by transfected cells. In this context, Chinese hamster ovary cells (CHO-S) are transfected in microchip with different types of lipoplexes (R+/- 1.5, 3, 5) and monitored by green fluorescent protein (GFP) production and cell viability. The single-cell platform enables to assess the heterogeneities of CHO-S population, revealing the presence of a subpopulation producing significantly high levels of GFP. These high producers (HP) show increased cell size in comparison to the average population. Moreover, the charge of lipoplexes shows an important role to transfect CHO-S, since the unique positive charged lipoplex R+/- 5 produces more HPs. Additionally, the amount of pDNA delivered affects the protein production, since R+/- 1.5 with more pDNA increase GFP specific productivity of HPs. This thesis is a co-supervised program between University of Campinas, Brazil and École Polytechnique, France. In general, this work contributes to microfluidics and gene delivery areas.

The biggest hurdle in success of gene and drug therapy is designing and preparation of suitable bio-nanomaterials to carry the desired nucleic acid and drug to the targeted site. The work described in the present thesis encompasses two different approaches for the delivery of bioactive oligo/polynucleotides and drugs in vitro and in vivo using either cationic lipids or their nanocomposites with different carbon nanomaterials. The idea of using carriers for oligo/polynucleotides and drugs came into existence because of numerous physiological barriers in pathway of delivery of naked oligo/polynucleotides or drugs which reduces the overall activity of these bioactives in biological systems. These barriers trigger scientific research toward the preparation of appropriate biomaterials which can overcome the physiological barriers and improve the activity of bioactive oligo/polynucleotides and drugs in cellular systems. Toward this end, the design and synthesis of different cationic lipids and carbon nanomaterials were undertaken as described in seven chapters of the thesis. A series of novel cationic lipids with structural variability was prepared and used for gene delivery in vitro. They were further tuned chemically to sustain delivery efficiency in high serum percentage during in vitro transfection. These serum compatible lipids were used to perform transfection of reporter gene plasmid and found to be more efficient compared to the some well known commercial products for the same purpose. Another series of novel lipids were synthesized for the targeted gene delivery in vitro. These tryptophan based cholesteryl lipids were used to prepare mixed liposomes. These mixed liposomes were highly efficient in targeting sigma receptor rich HEK293T over sigma receptor negative HeLa cells. Mixed liposomes were also prepared for selective targeting of αvβ3 and αvβ5 integrins in gene transfection protocol using a palmitoyl-RAFT-RGD4 template. A mixed liposomal formulation was developed to carry out anti-sense siRNA mediated knockdown of Smad-2 protein with better efficiency compared to some of the best known commercial products for the same purpose. These mixed liposomes were also highly efficient for regression via induction of p53 mediated apoptosis in xenograft tumors developed in nude mice. Carbon nanomaterials have been extensively explored as nanoscale gene/drug carriers for potential applications. But the challenge is to solubilize these highly hydrophobic materials in aqueous medium for use in biological systems. Although there are reports for covalent modifications of such nanomaterials but it could be done only with the loss of some beneficial features of these materials. Herein a non-covalent technique has been efficiently used to suspend single walled carbon nanotubes in water using biocompatible cationic lipids. These nanosuspensions were used to complex plasmid DNA and transfect them in vitro. They proved to be highly serum compatible DNA carriers which did not drop the efficiency even in very high percentage of serum. Similarly exfoliated graphene was modified with cationic lipid and serum components to improve IC50 of Tamoxifen citrate and Methotrexate to a considerable extent in vitro. The improved Methotrexate formulations were highly efficient for regression in size of xenograft tumors developed in nude mice. Thus, the present thesis entails generation of cationic lipids and carbon nanomaterials based nanocomposites which were not only highly biocompatible themselves but their efficiency was found many fold better compare to some of the best commercial delivery agents. These were useful for the delivery of various bioactive oligo/polynucleotides and drugs in vitro and in vivo.

Targeting the anticancer agents selectively to cancer cells is desirable to improve the efficacy and to reduce the side effects of anticancer therapy. Previously reported passive tumor targeting by PEGylated liposomes (stealth liposomes) have resulted in their higher tumor accumulation. However their interaction with cancer cells has been minimal due to the steric hindrance of the PEG coating. This dissertation reports two approaches to enhance the interaction of stealth liposomes with cancer cells. First, we designed a lipid-hydrazone-PEG conjugate that removes the PEG coating at acidic pH as in the tumor interstitium. However, such a conjugate was highly unstable on shelf. Targeting the anticancer agents selectively to cancer cells is desirable to improve the efficacy and to reduce the side effects of anticancer therapy. Previously reported passive tumor targeting by PEGylated liposomes (stealth liposomes) have resulted in their higher tumor accumulation. However their interaction with cancer cells has been minimal due to the steric hindrance of the PEG coating. This dissertation reports two approaches to enhance the interaction of stealth liposomes with cancer cells. First, we designed a lipid-hydrazone-PEG conjugate that removes the PEG coating at acidic pH as in the tumor interstitium. However, such a conjugate was highly unstable on shelf. Second we developed lipids with imidazole headgroups. Such lipids can protonate to provide positive charges on liposome surface at lowered pH. Additionally, negatively charged PEGylated phospholipids can cluster with the protonated imidazole lipids to display excess positive charges on the surface of the liposomes, thus enhancing their interaction with negatively charged cancer cells. We prepared convertible liposome formulations I, II and III consisting of one of the three imidazole-based lipids DHI, DHMI and DHDMI with estimated pKa values of 5.53, 6.2 and 6.75, respectively. Zeta potential measurement confirmed the increase of positive surface charge of such liposomes at lowered pHs. DSC studies showed that at pH 6.0 formulation I formed two lipid phases, whereas the control liposome IV remained a one-phase system at pHs 7.4 and 6.0. The interaction of such convertible liposomes with negatively charged model liposomes mimicking biomembranes at lowered pH was substantiated by 3-4 times increase in average sizes of the mixture of the convertible liposomes and the model liposomes at pH 6.0 compared to pH 7.4. The doxorubicin-loaded convertible liposomes show increased cytotoxicity in B16F10 (murine melanoma) and Hela cells at pH 6.0 as compared to pH 7.4. Liposome III shows the highest cell kill at pH 6.0 for both the cells. The control formulation IV showed no difference in cytotoxicity at pH 7.4 and 6.0. Uptake of convertible liposome II by B16F10 cells increased by 57 % as the pH was lowered from 7.4 to 6.0.

The thesis entitled “Novel Cationic Gemini Lipids, Click Chemistry Based Adducts and Amphiphile-Capped Silver Nanostructures: Synthesis, Aggregation and Biological Properties” elucidates the design, synthesis, aggregation and gene transfection properties of novel gemini cationic lipids based on cholesterol and pseudoglyceryl backbone, and click chemistry based adducts. This thesis also elucidates the synthesis and aggregation properties of silver nanoparticles loaded cationic liposomes and silver nanorods stabilized by micellar solutions of gemini surfactants. The work has been divided into six chapters. Chapter 1: Introduction: Membrane Formation from Cholesterol-based Cationic Lipids and their use as Non-Viral Gene Delivery Agents This chapter describes the importance of cholesterol in biological membranes, the aggregation properties of cholesterol-based cationic lipids and their interactions with phospholipid membranes. This chapter also gives a comprehensive account of the research towards the development of novel cationic cholesterol-based monomeric and gemini lipids. It also reviews the utilization of cholesterol-based cationic monomeric and gemini lipids in gene transfection properties. Chapter 2A: Effect of Hydroxyl group on the Cationic Headgroups of Cholesterol-based Gemini Lipids on their Aggregation, DNA Binding Properties and Interaction with Phospholipid Membranes This chapter describes the syntheses and aggregation properties of two series of cholesterol-based monomeric and gemini cationic lipids with and without hydroxyl functionality (Figure 1). The gemini lipids of a given series differ in their spacer polymethylene -(CH2)n- chain lengths between the cationic headgroups. Figure 1. Molecular structures of non-hydroxylated and hydroxylated cationic cholesterol-based gemini lipids and their monomeric counterparts. All monomeric and gemini lipids were found to generate stable suspensions in aqueous media. Electron microscopic studies showed that all the lipids form vesicular aggregates in aqueous media. The structures seen under TEM for the non-hydroxylated series of monomeric (C-M) and gemini lipids are of variable sizes, they appeared like separated vesicular aggregates. For the hydroxylated series of lipids, however, both the monomeric lipid aggregates (CH-M) and aggregates of their gemini counterparts were found to be ‘connected’ with each other to form elongated chain of aggregates of different length scales. XRD studies with the cast films of lipids revealed that the monomeric lipids of either series have higher bilayer width than the corresponding gemini lipids. Incorporation of the -(CH2)n- spacer units at the head group level joining the two monomeric units lowered the bilayer thicknesses of both series of the lipid aggregates. Thus the monomeric lipids (C-M and CH-M) appear to form nearly regular bilayer type arrangements whereas gemini lipids form interdigited and tilted bilayer arrangements in their aggregates. Calorimetry studies of the coaggregates showed that ~10 mol-% of most of the cholesterol gemini lipids is enough to abolish the phase transition of DPPC membranes whereas more than 10 mol-% is required in case of their monomeric counterparts. Further these thermotropic properties depend upon the length of the spacer of the gemini lipid included in the mixture. We have observed greater quenching of the thermal phase transition of DPPC membranes with 10 mol-% of C-M as compared to CH-M doped liposomes. At 10 mol-% of all the cationic lipid doped DPPC covesicles, only CG-3 doped liposomes showed an observable transition temperature. Maximum broadening of the DPPC transition peak was observed in the case of the gemini lipids, CHG-6 and CHG-12. DNA binding and release studies show that the interactions between gemini lipids and DNA depend upon the nature of the head group as well as the length of the spacer between the cationic head groups. For the non-hydroxylated cholesterol-based cationic lipid series, the monomeric liposomes of C-M facilitates the dissociation of EB from the EB-DNA complex to an extent of 93% at a maximum lipid:DNA ratio of 3.0 whereas the liposomes of CG-4 and CG-12 showed the lowest extent of maximum EB exclusion (~74%) from the EB-DNA complex at lipid:DNA ratio of 3.0. For hydroxylated cholesterol-based cationic lipid series, the monomeric liposomes of CH-M facilitate the dissociation of EB from the intercalated EB-DNA complex to an extent of 81 % whereas the liposomes of CHG-3 showed the minimum binding to DNA. Thus the two monomeric liposomes C-M and CH-M were the more efficient formulations that allow dissociation of DNA from the corresponding lipoplexes. These findings have important being in their gene transfection activity compared their respective gemini lipid counterparts. Chapter 2B: Novel Cholesterol-based Cationic Gemini Lipids possessing Hydroxyethyl group on the Headgroup: Transfection Efficacy and Cell Toxicity Properties This chapter describes the transfection efficacy and cell toxicity properties of five cholesterol based gemini cationic lipids possessing hydroxyethyl functionality on each head group, which differ in the length of the polymethylene spacer [-(CH2)n-] chain (Figure 2). These gemini lipids are important to gene delivery processes as they possess pre-optimized molecular features, e.g., cholesterol backbone, ether linkage and a variable spacer chain between both the headgroups of the gemini lipids. Cationic liposomes were prepared from each of these lipids individually and as a mixture of individual cationic gemini lipid and 1,2-dioleoylphosphatidylethanolamine (DOPE). The gemini lipid with a hydroxyethylated headgroup and a -(CH2)5- spacer, CHG-5 showed the highest transfection activity at N/P (lipid/DNA) ratio of 0.5 and lipid:DOPE molar ratio of 2. Upon comparison of the relevant parameters, e.g., % transfected cells, the amount of DNA transfected to each cell and % cell viability all together against LipofectAMINE 2000, one of the most potent commercially available transfecting agents, the optimized lipid formulation based on CHG-5/DOPE was found to be comparable. In terms of its ability to induce gene-transfer in presence of serum and shelf-life CHG-5/DOPE liposome was found to be better than its commercial counterpart. Recording of confocal images confirmed that in presence of 10% serum using 1.2 µg DNA per well and lipid:DOPE ratio of 1:4 and N/P charge ratio of 0.75, CHG-5 is better than LipofectAMINE 2000. These properties render them to be reagents of practical value for various gene delivery applications. Figure 2. Molecular structures of cholesterol-based cationic monomeric lipid and gemini lipids possessing hydroxyethyl group on the headgroup synthesized. Chapter 3: Bilayer Membrane and Stable Monolayer Forming Properties of Cationic Pseudoglyceryl Gemini Lipids having Polymethylene Spacers and Oxyethylene Linkages This chapter describes the synthesis of five new cationic pseudoglyceryl gemini lipid versions of their monomeric counterpart (Figure 3). Each cationic lipid aggregate in aqueous media was found to form vesicular structures as evidenced from the negatively stained TEM experiments and DLS measurements. XRD experiments with their cast films of aqueous dispersions revealed that introduction of the polymethylene -(CH2)n-spacer chain joining the two monomers decreased the bilayer widths of the gemini lipid aggregates. The inter-lipidic packing and the hydration of the lipid vesicles were examined using fluorescence anisotropy and generalized polarization measurements using membrane-soluble probes, DPH and Paldan respectively. Fluorescence anisotropy measurements showed that the aggregates of lipid 2c with -(CH2)5- spacer chain were highly packed and ordered in the vesicular aggregates than that of the other cationic lipid aggregates in the series. Paldan hydration studies showed that incorporation of the polymethylene -(CH2)n- spacer chains joining two monomeric units lowered the hydration of the gemini lipid aggregates in the solid gel state. Each of these cationic lipid aggregates showed sharp transition temperatures (Tm) as observed from differential scanning calorimetric studies. DSC studies further revealed that the incorporation of oxyethylene group at the linker region of cationic pseudoglyceryl gemini lipid 2a with (CH2)3- spacer chain length lowered the thermotropic phase transition temperature (Tm) of the aggregates in aqueous media when compared with the corresponding gemini analogue without oxyethylene linkages. Langmuir film balance studies showed that each cationic gemini lipid and their monomeric counterpart were able to form stable monolayers at the air-water interphase. We observed that the mean molecular area (collapse area) of each of the cationic lipid obtained from the Langmuir monolayer studies increased with increase in the spacer chain lengths. Figure 3. Molecular structures of the cationic pseudoglyceryl gemini lipids and their monomeric counterpart. Chapter 4: Vesicle and Stable Monolayer Formation from Simple ‘Click’ Chemistry Adducts in Water This chapter describes successful use of Cu(I) catalyzed “Click Chemistry” for the syntheses of a series of hitherto unknown amphiphilic adducts (M1, M2, D1 and T1) which on dispersal in water afforded vesicular aggregates as evidenced from dye entrapment, TEM, SEM, AFM and DLS studies (Figure 4). Figure 4. Molecular structures of triazole based adducts. XRD experiments with their cast films of aqueous suspensions indicate the formation of a tilted bilayer arrangement for the aggregates of M1 whereas regular bilayer structures are predominant for the aggregates derived from M2, D1 and T1. Measurement of pKa values using UV-Vis spectroscopy showed that the aggregates of monomeric click adducts (M1 and M2) possess less pKa value than that of the aggregates of dimeric (D1) and tetrameric (T1) analogues and the values lie within the range of 2.8-3.2. The hydrodynamic diameter of the aggregates of each click adduct increased with decrease in the pH of the media. Thus, the protonation of the triazole groups in the aggregates of each click adduct increased the hydrodynamic diameter. Dye entrapment studies showed that each click chemistry based adduct formed closed vesicular aggregates with inner aqueous compartment in aqueous media. The temperature induced order-to-disorder transitions of the aggregates and the accompanying changes in hydration were examined using high sensitive DSC, fluorescence anisotropy and generalized polarization measurements using a membranesoluble probe, DPH and Paldan respectively. In the solid state, M1 remains as the most hydrated species whereas in the fluidized phase, D1 maintains as the most hydrated aggregate. Clearly simple variation in the adduct molecular architecture bring about significant changes in their packing in aggregates and also the hydration of the resulting vesicles. Langmuir monolayer studies confirmed that these click adducts do form stable monolayers as well on water subphase at the air-water interface. We also calculated the mean molecular areas from the Langmuir monolayer studies and as perhaps expected the adduct T1 has the highest head group area. Thus click chemistry based simple triazole adducts, which can be very easily prepared, are good candidates for further investigations involving syntheses of novel self-assembling structures. Chapter 5: Lipid Mediated Synthesis of Silver Nanoparticles, their Physical Characterizations and DNA Binding Abilities In this chapter, work on the Ag-NP (silver nanoparticle) loaded liposomes preparation using four cationic lipids (1-4) in which the Ag-NPs were entrapped within lipid bilayer has been described. A novel method was developed to synthesize the Ag-NPs where the lipid itself capped and stabilized the Ag-NPs. Consequently there was no need of inclusion of any other capping agents like citrate. Confocal microscopy confirmed that these Ag-nanoparticles are fluorescent in character. It was also demonstrated that silver nanoparticles are indeed entrapped in lipid bilayer with transmission electron microscopy (TEM). DLS experiments provided information about the hydrodynamic diameter of the lipid vesicles which increased with the increase in Ag concentrations. This could be due to the ‘loosening’ of the lipid packing in vesicles. Zeta potential measurements showed that the zeta potential value decreased with the increase in the concentration of Ag-NPs in the cationic lipid vesicles. XRD studies with the cast films of the lipid or Ag-NP loaded lipid suspensions revealed that when the Ag-NPs get entrapped into the bilayer of the multilamellar vesicles of the lipid in the aqueous media, the unit bilayer thickness of the aggregates increased. Paldan experiments showed that with the incorporation of Ag-NPs in the lipid vesicles, the hydration of the lipid vesicles increased to a significant extent but the phase transition temperatures remained practically unaltered for all the lipids. Fluorescence anisotropy experiments revealed that the hydrocarbon chain packing of the lipid vesicles ‘loosens’ with the incorporation of Ag-NPs. Ag-NP loaded liposomes showed enhanced DNA binding ability and also the presence of Ag-NPs in cationic liposomes induced the release of DNA from silver nanoparticle-loaded lipoplexes more effectively. Figure 5. Molecular structures of the cationic lipids mentioned in the present chapter. Chapter 6: Dependence of Spacer Chain Lengths in the Synthesis of Ag-Nanorods in Gemini Cationic Surfactant Micelles Figure 6. Chemical structures of cationic gemini surfactants. This chapter describes the synthesis of Ag-nanospecies by seed-mediated wet synthesis method using four gemini surfactants (16-2-16, 16-4-16, 16-5-16 and 16-1216) as the capping agents (Figure 6). For this, we first synthesized Ag-nanoseeds of diameter ~7 nm stabilized by trisodium citrate (as capping agent). Then the solution containing Ag-nanoseeds was used to synthesize Ag-nanorods of different aspect ratios. It was that with decreasing Ag-nanoseed concentration, the aspect ratios of Agnanorods stabilized by gemini surfactants (16-2-16 and 16-4-16) increased gradually as evidenced from TEM images. These Ag-nanoseeds and Ag-nanorods were further characterized using UV-Vis spectroscopy (to know the surface plasmon bands), transmission electron microscopy (TEM), energy-dispersive X-ray spectroscopy (EDAX) and X-ray diffraction (XRD). It was observed that when gemini surfactant 164-16 was used to stabilize Ag-nanorods, the λmax of the longitudinal band shifted more towards the red region (red-shift) as observed by UV-Vis spectroscopy when compared to that of gemini surfactant with shortest spacer, 16-2-16. Thus the gemini surfactants with shorter -(CH2)2- and -(CH2)4- spacer chains promoted the growth of Ag-nanorods in their micellar solutions whereas -(CH2)5- and -(CH2)12- spacer chains of gemini surfactants did not. So, the growth of Ag-nanorods in micellar solutions is found to be highly spacer-chain length specific. TEM micrographs revealed that the aspect ratios of Ag-nanorods stabilized by gemini surfactants 16-4-16 are larger than those compared to the Ag-nanorods stabilized by gemini surfactants 16-2-16 at a particular amount of Agnanoseed solution. TEM images of the samples containing micellar solutions of gemini surfactants 16-5-16 and 16-12-16 showed that the formation of only Ag-nanoparticles of larger sizes (compared to Ag-nanoseeds stabilized by trisodium citrate) and Agnanoprisms irrespective of the amount of Ag-nanoseed solution added. No Ag-nanorod formation in the micellar solutions of gemini surfactants 16-5-16 and 16-12-16 was observed. Gemini surfactants (16-2-16 and 16-4-16) formed bilayer arrangements to facilitate the growth and stabilization of Ag-nanorods in aqueous media where the inner layer is attached to the Ag-nanorod surface through the gemini surfactant ammonium headgroups. X-ray diffraction (XRD) studies showed that these Ag-nanorods stabilized by gemini surfactants 16-2-16 and 16-4-16 crystallized in the aqueous media via (111), (220) and (222) lattice faces. Thus this study demonstrated the way one can control structures and shapes of the silver nanoobjects using gemini surfactant micelles. (For structural formula pl refer the thesis)